Maprotiline hydrochloride
SIGMA/M9651 - >99% (HPLC), powder
Synonym: 9-(γ-Methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene hydrochloride
CAS Number: 10347-81-6
Empirical Formula (Hill Notation): C20H23N · HCl
Molecular Weight: 313.86
EC Number: 233-758-8
MDL Number: MFCD00079464
Linear Formula: C20H23N · HCl
Product Type: Chemical
| assay | >99% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C20H23N.ClH/c1-21-14-6 |
| InChI key | NZDMFGKECODQRY-UHFFFAOYSA |
| originator | Novartis |
| Quality Level | 200 ![]() |
| SMILES string | Cl.CNCCCC12CCC(c3ccccc13) |
| solubility | H2O: 50 mg/mL |
| Application: | Maprotiline hydrochloride has been used as a inhibitor of norepinephrine uptake to study its effects on arresting L3055 cell proliferation. |
| Biochem/physiol Actions: | Maprotiline is a tetracyclic agent. It possesses inhibitory effects against the uptake of norepinephrine by nerve cells. Maprotiline exhibits anti-depressant and sedative activity. |
| Features and Benefits: | This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | >99% (HPLC) |
| UNSPSC | 12352200 |


